Clough Capital Partners’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Buy |
+24,850
| New | +$318K | 0.03% | 114 |
|
|
2025
Q1 | – | Sell |
-38,519
| Closed | -$505K | – | 122 |
|
|
2024
Q4 | $505K | Hold |
38,519
| – | – | 0.06% | 103 |
|
|
2024
Q3 | $581K | Sell |
38,519
-36,110
| -48% | -$545K | 0.06% | 110 |
|
|
2024
Q2 | $1.06M | Sell |
74,629
-45,011
| -38% | -$638K | 0.12% | 85 |
|
|
2024
Q1 | $1.63M | Sell |
119,640
-255,770
| -68% | -$3.49M | 0.18% | 74 |
|
|
2023
Q4 | $5.05M | Buy |
375,410
+244,960
| +188% | +$3.3M | 0.56% | 51 |
|
|
2023
Q3 | $1.63M | Buy |
+130,450
| New | +$1.63M | 0.17% | 105 |
|
|
2020
Q4 | – | Sell |
-58,926
| Closed | -$1.04M | – | 143 |
|
|
2020
Q3 | $1.04M | Buy |
58,926
+19,200
| +48% | +$338K | 0.07% | 88 |
|
|
2020
Q2 | $713K | Buy |
+39,726
| New | +$713K | 0.07% | 108 |
|
|
2017
Q2 | – | Sell |
-48,545
| Closed | -$825K | – | 150 |
|
|
2017
Q1 | $825K | Hold |
48,545
| – | – | 0.05% | 109 |
|
|
2016
Q4 | $825K | Buy |
+48,545
| New | +$825K | 0.05% | 124 |
|
|
2016
Q3 | – | Sell |
-30,922
| Closed | -$532K | – | 196 |
|
|
2016
Q2 | $532K | Buy |
+30,922
| New | +$532K | 0.03% | 157 |
|
|
2015
Q4 | – | Sell |
-8,900
| Closed | -$200K | – | 210 |
|
|
2015
Q3 | $200K | Buy |
+8,900
| New | +$200K | 0.01% | 169 |
|